Qualification of Drivers; Exemption Applications; Diabetes, 17157-17159 [E6-4898]
Download as PDF
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices
McVaugh, Mayor, Village of Hamilton,
PO Box 119, 3 Broad Street, Hamilton,
New York 13346.
Mr.
Otto N. Suriani, Acting Manager, New
York Airport District Office, 600 Old
County Road, Suite 446, Garden City,
New York 11530; telephone (516) 227–
3809; Fax (516) 227–3813; e-mail
Otto.Suriani@FAA.Gov.
FOR FURTHER INFORMATION CONTACT:
On April
5, 2000, new authorizing legislation
became effective. That bill, the Wendell
H. Ford Aviation Investment and
Reform Act for the 21st Century, Public
Law 10–181 (Apr. 5, 2000; 114 Stat. 61)
(AIR 21) requires that a 30 day public
notice must be provided before the
Secretary may waive any condition
imposed on an interest in surplus
property.
SUPPLEMENTARY INFORMATION:
Issued in Garden City, New York, on
March 29, 2006.
Otto N. Suriani,
Acting Manager, New York Airports District
Office, Eastern Region.
[FR Doc. 06–3247 Filed 4–4–06; 8:45 am]
BILLING CODE 4910–13–M
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2005–22177]
Qualification of Drivers; Exemption
Applications; Diabetes
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
AGENCY:
ACTION:
Notice of final disposition.
FMCSA announces its
decision to exempt two individuals
from its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
SUMMARY:
The exemptions are effective
April 5, 2006. The exemptions expire on
April 7, 2008.
DATES:
Dr.
Mary D. Gunnels, Chief, Physical
Qualifications Division, (202) 366–4001,
maggi.gunnels@fmcsa.dot.gov, FMCSA,
Department of Transportation, 400
Seventh Street, SW., Washington, DC
20590–0001. Office hours are from 8
a.m. to 5 p.m., e.t., Monday through
Friday, except Federal holidays.
wwhite on PROD1PC61 with NOTICES
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
18:34 Apr 04, 2006
Jkt 208001
Electronic Access
You may see all the comments online
through the Document Management
System (DMS) at: https://dmses.dot.gov.
Docket: For access to the docket to
read background documents or
comments received, go to https://
dms.dot.gov and/or Room PL–401 on
the plaza level of the Nassif Building,
400 Seventh Street, SW., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
complete Privacy Act Statement in the
Federal Register (65 FR 19477, Apr. 11,
2000). This statement is also available at
https://dms.dot.gov.
Background
Authority To Grant Exemptions
Section 4007 of the Transportation
Equity Act for the 21st Century (Public
Law 105–178, 112 Stat. 107, June 9,
1998) (TEA–21) amended 49 U.S.C.
31315 and 31136(e) to provide FMCSA
with authority to grant exemptions from
its safety regulations. On December 8,
1998, the Federal Highway
Administration’s Office of Motor
Carriers, the predecessor to FMCSA,
published an interim final rule
implementing section 4007 (63 FR
67600). On August 20, 2004, FMCSA
published a final rule (69 FR 51589) on
this subject. By this rule, FMCSA must
publish a Notice of each exemption
request in the Federal Register (49 CFR
part 381), provide the public with an
opportunity to inspect the information
relevant to the application to include
any safety analyses that have been
conducted, and provide an opportunity
for public comment on the request.
The Agency must then examine the
safety analyses and the public
comments, and determine whether the
exemption would achieve a level of
safety equivalent to, or greater than, the
level that would be achieved by
complying with the current regulation
(49 CFR 381.305). The Agency’s
decision must be published in the
Federal Register (49 CFR 381.315(b)). If
the Agency denies the request, it must
state the reason for doing so. If the
decision is to grant the exemption, the
Notice must specify the person or class
of persons receiving the exemption, and
the regulatory provision or provisions
from which an exemption is being
granted. The Notice must also specify
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
17157
the effective period of the exemption
(up to two years), and explain the terms
and conditions of the exemption. The
exemption may be renewed (49 CFR
381.300(b)).
Establishment of FMCSA’s Diabetes
Exemption Program
FMCSA published a Notice of intent
to issue exemptions to drivers with
ITDM on July 31, 2001 (66 FR 39548).
On September 3, 2003, the Agency
published a Notice of final disposition
announcing its decision to issue
exemptions to certain insulin-using
diabetic drivers of CMVs from the
diabetes mellitus prohibition under 49
CFR 391.41(b)(3). [68 FR 5241] (‘‘2003
Notice’’). The 2003 Notice explained
that in considering exemptions, FMCSA
must ensure that the issuance of
diabetes exemptions will not be
contrary to the public interest and that
the exemption achieves an acceptable
level of safety. The Agency indicated it
will only grant exemptions to insulinusing diabetic drivers that meet the
eligibility criteria provided in its notice
of final disposition.
Because FMCSA established
eligibility criteria for use in determining
whether the granting of a diabetes
exemption would achieve the requisite
level of safety, the Agency only
publishes for public comment, the
names of exemption applicants that
satisfy the eligibility requirements,
based upon the information provided by
the applicant. Applicants that do not
meet the requirements are notified by
letter that their applications are denied
and the Agency periodically publishes
the names of those individuals to satisfy
the statutory requirement for disclosing
such information to the public.
Safe, Accountable, Flexible, Efficient
Transportation Equity Act: A Legacy for
Users (SAFETEA–LU)
Section 4129 of SAFETEA–LU (Public
Law 109–59, 119 Stat., August 10, 2005)
required FMCSA to revise its diabetes
exemption program established on
September 3, 2003 (68 FR 52441). The
revision must provide for individual
assessment of drivers with ITDM, and
be consistent with the criteria described
in section 4018 of TEA–21.1 Section
4129 required two substantive changes
to be made in the exemption process set
out in the 2003 Notice.
In response to section 4129, FMCSA
made immediate revisions to the
diabetes exemption program established
1 Section 4129(a) refers to the 2003 notice as a
‘‘final rule.’’ However, as indicated above, the 2003
Notice did not issue a ‘‘final rule’’ but did establish
the procedures and standards for issuing
exemptions for drivers with ITDM.
E:\FR\FM\05APN1.SGM
05APN1
17158
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices
wwhite on PROD1PC61 with NOTICES
by the September 3, 2003 Notice. These
revisions by FMCSA were necessary to
respond to the specific changes
mandated by section 4129(b) and (c).
The changes are: (1) The elimination of
the requirement for three years of
experience operating CMVs while being
treated with insulin; and (2) the
establishment of a specified minimum
period of insulin use to demonstrate
stable control of diabetes before being
allowed to operate a CMV. Section
4129(d) also directed FMCSA to ensure
that CMV drivers with ITDM are not
held to a higher standard than other
drivers, with the exception of limited
operating, monitoring and medical
requirements that are deemed medically
necessary. FMCSA concluded that all of
the operating, monitoring and medical
requirements set out in the 2003 Notice,
except as modified, were in compliance
with section 4129(d). Therefore, all of
the requirements set out in the 2003
Notice, other than those modified in the
November 8, 2005 (70 FR 67777)
Federal Register Notice, remain in
effect.
On October 19, 2005, FMCSA
published a Notice of receipt of diabetes
exemption applications from three
individuals, and requested comments
from the public (70 FR 60875). The
three individuals are: Doyle F. Heiner,
James R. Moretz, and Uve J. Witsch. The
public comment period closed on
November 18, 2005. Three comments
were received through the DMS and one
comment was received by telephone in
regard to Uve. J. Witsch. All comments
have been fully considered by FMCSA
in reaching the final decision whether to
grant the exemptions.
FMCSA has evaluated the eligibility
of the three applicants and made a
determination that granting the
exemptions to two of these individuals
would achieve a level of safety
equivalent to, or greater than, the level
that would be achieved by complying
with the current regulation 49 CFR
391.41(b)(3). FMCSA is at this time
unable to determine if granting the third
exemption would achieve the same
level of safety. A request for additional
information has been sent to Mr. Witsch
to assist the Agency in making this
determination.
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
several risk studies indicated that
diabetic drivers had a higher rate of
crash involvement than the general
population. The diabetes rule provides
that—A person is physically qualified to
drive a commercial motor vehicle if that
VerDate Aug<31>2005
16:10 Apr 04, 2006
Jkt 208001
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control (49 CFR 391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some insulin-treated diabetic
drivers to operate CMVs is feasible. The
2003 Notice in conjunction with the
November 8, 2005 (70 FR 67777)
Federal Register Notice provides the
current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These three applicants have had
ITDM over a range of 5 to 9 years. These
applicants report no hypoglycemic
reaction that resulted in loss of
consciousness or seizure, that required
the assistance of another person, or
resulted in impaired cognitive function
without warning symptoms in the past
5 years (with one year of stability
following any such episode). In each
case, an endocrinologist has verified
that the driver has demonstrated
willingness to properly monitor and
manage their diabetes, received
education related to diabetes
management, and is on a stable insulin
regimen. These drivers report no other
disqualifying conditions, including
diabetes-related complications. Each
meets the vision standard at 49 CFR
391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the October
19, 2005, Notice (70 FR 23904). Because
there were no docket comments on the
specific merits or qualifications of any
applicant, we have not repeated the
individual profiles here.
Basis for Exemption Determination
Under 49 U.S.C. 31315 and 31136(e),
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologist’s
medical opinion related to the ability of
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that
exempting two of these applicants from
the diabetes standard in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption. The Agency is granting
the exemptions for the 2-year period
allowed by 49 U.S.C. 31315 and
31136(e) to Doyle F. Heiner and James
R. Moretz. Once the Agency has
received the requested information from
Mr. Witsch, it will be reviewed, and a
final determination will be published in
a separate Federal Register Notice.
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document.
Discussion of Comments
FMCSA received three comments in
this proceeding through the DMS. The
comments were considered and are
discussed below.
Heather M. Murphy commented that
she does not believe that it is fair that
an insulin dependent person is now
able to receive an exemption to drive in
interstate commerce without three years
of driving experience while taking
insulin, and individuals applying for a
Federal vision exemption must still
meet this three years of experience
requirement. She believes that all
exemptions should go by the same
standards and she requests that FMCSA
reconsider the Federal vision exemption
requirements.
FMCSA recognizes the current
differences between the Federal
Diabetes Exemption Program and the
Federal Vision Exemption Program
related to driving experience criteria.
FMCSA has used recent driving
experience in evaluating future safety,
based on several research studies
designed to correlate past and future
driving performance. Results of these
studies support the principle that the
best predictor of future performance by
a driver is his/her past record of crashes
and traffic violations. Copies of these
studies may be found at docket number
FMCSA–98–3637. The implementation
of SAFETEA–LU mandated the removal
of the three year driving requirement
from the Federal diabetes exemption
eligibility criteria.
The Agency has begun initiatives to
evaluate if the driving experience
criteria should remain part of the
Federal Vision Exemption Program.
FMCSA has begun a Federal Vision
Exemption Program evaluation. One
portion of this evaluation will focus on
determining if drivers with certain
E:\FR\FM\05APN1.SGM
05APN1
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices
visual deficiencies are as safe or safer
than drivers in the general population.
FMCSA also published a Federal
Register Notice announcing the
establishment of a Medical Review
Board (MRB) on October 3, 2005 (70 FR
57642). The MRB is scheduled to review
the vision standard during the third
quarter of 2006. The driving experience
criteria will remain in effect for the
Federal Vision Exemption Program until
the conclusion of these initiatives.
Two additional comments received
were in favor of granting the exemptions
and supported the approach FMCSA
takes in evaluating the exemption
candidates.
below has been forwarded to the Office
of Management and Budget (OMB) for
review and comment. The ICR describes
the nature of the information collections
and their expected burden. The Federal
Register Notice with a 60-day comment
period was published on January 11,
2006 [Volume 71, No. 7, Page 1782].
DATES: Comments must be submitted on
or before May 5, 2006.
FOR FURTHER INFORMATION CONTACT: Gary
Toth, NHTSA, 400 Seventh Street, SW.,
Room 6213, NPO–111, Washington, DC
20590. The telephone number for Mr.
Toth is (202) 366–5378.
SUPPLEMENTARY INFORMATION:
Conclusion
After considering the comments to the
docket and based upon its evaluation of
the 3 exemption applications, FMCSA
exempts Doyle F. Heiner and James R.
Moretz from the diabetes requirement in
49 CFR 391.41(b)(3), subject to the
conditions listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31315
and 31136(e), each exemption will be
valid for two years unless revoked
earlier by FMCSA. The exemption will
be revoked if: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
objectives of 49 U.S.C. 31315 and 31136.
If the exemption is still effective at the
end of the 2-year period, the person may
apply to the FMCSA for a renewal under
procedures in effect at that time.
National Highway Traffic Safety
Administration
Issued on: March 29, 2006.
Rose A. McMurray,
Associate Administrator, Policy and Program
Development.
[FR Doc. E6–4898 Filed 4–4–06; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
National Highway Traffic Safety
Administration
Reports, Forms and Recordkeeping
Requirements; Agency Information
Collection Activity Under OMB Review
National Highway Traffic
Safety Administration, DOT.
ACTION: Notice.
wwhite on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: In compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.), this notice
announces that the Information
Collection Request (ICR) abstracted
VerDate Aug<31>2005
16:10 Apr 04, 2006
Jkt 208001
Title: National Automotive Sampling
System (NASS).
OMB Number: 2127 0021.
Type of Request: Continuation.
Abstract: The collection of crash data
that support the establishment and
enforcement of motor vehicle
regulations that reduce the severity of
injury and property damage caused by
motor vehicle crashes is authorized
under the National Traffic and Motor
Vehicle Safety Act of 1966 (Pub. L. 89–
563, Title 1, Sec. 106, 108, and 112).
The National Automotive Sampling
System (NASS) Crashworthiness Data
System (CDS) of the National Highway
Traffic Safety Administration
investigates high severity crashes. Once
a crash has been selected for
investigation, researchers locate, visit,
measure, and photograph the crash
scene; locate, inspect, and photograph
vehicles; conduct a telephone or
personal interview with the involved
individuals or surrogate; and obtain and
record injury information received from
various medical data sources. NASS
CDS data are used to describe and
analyze circumstances, mechanisms,
and consequences of high severity
motor vehicle crashes in the United
States. The collection of interview data
aids in this effort.
Affected Public: Passenger Motor
Vehicle Operators.
Estimated Total Annual Burden:
5,807 hours.
Number of respondents: 13,500.
ADDRESSES: Send comments, within 30
days, to the Office of Information and
Regulatory Affairs, Office of
Management and Budget, 725–17th
Street, NW, Washington, DC 20503,
Attention NHTSA Desk Officer.
Comments are invited on: Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the Department,
including whether the information will
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
17159
have practical utility; the accuracy of
the Departments estimate of the burden
of the proposed information collection;
ways to enhance the quality, utility and
clarity of the information to be
collected; and ways to minimize the
burden of the collection of information
on respondents, including the use of
automated collection techniques or
other forms of information technology.
A Comment to OMB is most effective if
OMB receives it within 30 days of
publication.
Joseph S. Carra,
Associate Administrator for National Center
for Statistics and Analysis.
[FR Doc. E6–4915 Filed 4–4–06; 8:45 am]
BILLING CODE 4910–59–P
DEPARTMENT OF TRANSPORTATION
National Highway Traffic Safety
Administration
[Docket No. NHTSA–2006–24137; Notice 1]
General Motors Corporation, Receipt
of Petition for Decision of
Inconsequential Noncompliance
General Motors Corporation (GM) has
determined that certain 2006 model year
Cadillac XLR vehicles do not comply
with S7.8.2.1(c) of 49 CFR 571.108,
Federal Motor Vehicle Safety Standard
(FMVSS) No. 108, ‘‘Lamps, reflective
devices, and associated equipment.’’
GM has filed an appropriate report
pursuant to 49 CFR part 573, ‘‘Defect
and Noncompliance Reports.’’
Pursuant to 49 U.S.C. 30118(d) and
30120(h), GM has petitioned for an
exemption from the notification and
remedy requirements of 49 U.S.C.
Chapter 301 on the basis that this
noncompliance is inconsequential to
motor vehicle safety.
This notice of receipt of GM’s petition
is published under 49 U.S.C. 30118 and
30120 and does not represent any
agency decision or other exercise of
judgment concerning the merits of the
petition.
Affected are a total of approximately
1,074 model year 2006 Cadillac XLR
vehicles produced between July 26,
2005 and November 3, 2005. S7.8.2.1(c)
of FMVSS No. 108 requires that if
visually/optically (VO) aimable
headlamps are equipped with horizontal
adjustment, then they must meet the
applicable headlamp aim requirements
in S7.8.5.2. The noncompliant
headlamps are equipped with a
horizontal adjustment but do not meet
the S7.8.5.2 requirements. GM explains
that during the assembly process the
horizontal adjuster is supposed to be
E:\FR\FM\05APN1.SGM
05APN1
Agencies
[Federal Register Volume 71, Number 65 (Wednesday, April 5, 2006)]
[Notices]
[Pages 17157-17159]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4898]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2005-22177]
Qualification of Drivers; Exemption Applications; Diabetes
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt two individuals from
its rule prohibiting persons with insulin-treated diabetes mellitus
(ITDM) from operating commercial motor vehicles (CMVs) in interstate
commerce. The exemptions will enable these individuals to operate CMVs
in interstate commerce.
DATES: The exemptions are effective April 5, 2006. The exemptions
expire on April 7, 2008.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical
Qualifications Division, (202) 366-4001, maggi.gunnels@fmcsa.dot.gov,
FMCSA, Department of Transportation, 400 Seventh Street, SW.,
Washington, DC 20590-0001. Office hours are from 8 a.m. to 5 p.m.,
e.t., Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Document Management
System (DMS) at: https://dmses.dot.gov.
Docket: For access to the docket to read background documents or
comments received, go to https://dms.dot.gov and/or Room PL-401 on the
plaza level of the Nassif Building, 400 Seventh Street, SW.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's complete Privacy Act Statement in the
Federal Register (65 FR 19477, Apr. 11, 2000). This statement is also
available at https://dms.dot.gov.
Background
Authority To Grant Exemptions
Section 4007 of the Transportation Equity Act for the 21st Century
(Public Law 105-178, 112 Stat. 107, June 9, 1998) (TEA-21) amended 49
U.S.C. 31315 and 31136(e) to provide FMCSA with authority to grant
exemptions from its safety regulations. On December 8, 1998, the
Federal Highway Administration's Office of Motor Carriers, the
predecessor to FMCSA, published an interim final rule implementing
section 4007 (63 FR 67600). On August 20, 2004, FMCSA published a final
rule (69 FR 51589) on this subject. By this rule, FMCSA must publish a
Notice of each exemption request in the Federal Register (49 CFR part
381), provide the public with an opportunity to inspect the information
relevant to the application to include any safety analyses that have
been conducted, and provide an opportunity for public comment on the
request.
The Agency must then examine the safety analyses and the public
comments, and determine whether the exemption would achieve a level of
safety equivalent to, or greater than, the level that would be achieved
by complying with the current regulation (49 CFR 381.305). The Agency's
decision must be published in the Federal Register (49 CFR 381.315(b)).
If the Agency denies the request, it must state the reason for doing
so. If the decision is to grant the exemption, the Notice must specify
the person or class of persons receiving the exemption, and the
regulatory provision or provisions from which an exemption is being
granted. The Notice must also specify the effective period of the
exemption (up to two years), and explain the terms and conditions of
the exemption. The exemption may be renewed (49 CFR 381.300(b)).
Establishment of FMCSA's Diabetes Exemption Program
FMCSA published a Notice of intent to issue exemptions to drivers
with ITDM on July 31, 2001 (66 FR 39548). On September 3, 2003, the
Agency published a Notice of final disposition announcing its decision
to issue exemptions to certain insulin-using diabetic drivers of CMVs
from the diabetes mellitus prohibition under 49 CFR 391.41(b)(3). [68
FR 5241] (``2003 Notice''). The 2003 Notice explained that in
considering exemptions, FMCSA must ensure that the issuance of diabetes
exemptions will not be contrary to the public interest and that the
exemption achieves an acceptable level of safety. The Agency indicated
it will only grant exemptions to insulin-using diabetic drivers that
meet the eligibility criteria provided in its notice of final
disposition.
Because FMCSA established eligibility criteria for use in
determining whether the granting of a diabetes exemption would achieve
the requisite level of safety, the Agency only publishes for public
comment, the names of exemption applicants that satisfy the eligibility
requirements, based upon the information provided by the applicant.
Applicants that do not meet the requirements are notified by letter
that their applications are denied and the Agency periodically
publishes the names of those individuals to satisfy the statutory
requirement for disclosing such information to the public.
Safe, Accountable, Flexible, Efficient Transportation Equity Act: A
Legacy for Users (SAFETEA-LU)
Section 4129 of SAFETEA-LU (Public Law 109-59, 119 Stat., August
10, 2005) required FMCSA to revise its diabetes exemption program
established on September 3, 2003 (68 FR 52441). The revision must
provide for individual assessment of drivers with ITDM, and be
consistent with the criteria described in section 4018 of TEA-21.\1\
Section 4129 required two substantive changes to be made in the
exemption process set out in the 2003 Notice.
---------------------------------------------------------------------------
\1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, as indicated above, the 2003 Notice did not issue a
``final rule'' but did establish the procedures and standards for
issuing exemptions for drivers with ITDM.
---------------------------------------------------------------------------
In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established
[[Page 17158]]
by the September 3, 2003 Notice. These revisions by FMCSA were
necessary to respond to the specific changes mandated by section
4129(b) and (c). The changes are: (1) The elimination of the
requirement for three years of experience operating CMVs while being
treated with insulin; and (2) the establishment of a specified minimum
period of insulin use to demonstrate stable control of diabetes before
being allowed to operate a CMV. Section 4129(d) also directed FMCSA to
ensure that CMV drivers with ITDM are not held to a higher standard
than other drivers, with the exception of limited operating, monitoring
and medical requirements that are deemed medically necessary. FMCSA
concluded that all of the operating, monitoring and medical
requirements set out in the 2003 Notice, except as modified, were in
compliance with section 4129(d). Therefore, all of the requirements set
out in the 2003 Notice, other than those modified in the November 8,
2005 (70 FR 67777) Federal Register Notice, remain in effect.
On October 19, 2005, FMCSA published a Notice of receipt of
diabetes exemption applications from three individuals, and requested
comments from the public (70 FR 60875). The three individuals are:
Doyle F. Heiner, James R. Moretz, and Uve J. Witsch. The public comment
period closed on November 18, 2005. Three comments were received
through the DMS and one comment was received by telephone in regard to
Uve. J. Witsch. All comments have been fully considered by FMCSA in
reaching the final decision whether to grant the exemptions.
FMCSA has evaluated the eligibility of the three applicants and
made a determination that granting the exemptions to two of these
individuals would achieve a level of safety equivalent to, or greater
than, the level that would be achieved by complying with the current
regulation 49 CFR 391.41(b)(3). FMCSA is at this time unable to
determine if granting the third exemption would achieve the same level
of safety. A request for additional information has been sent to Mr.
Witsch to assist the Agency in making this determination.
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current standard for diabetes in 1970
because several risk studies indicated that diabetic drivers had a
higher rate of crash involvement than the general population. The
diabetes rule provides that--A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some insulin-treated diabetic
drivers to operate CMVs is feasible. The 2003 Notice in conjunction
with the November 8, 2005 (70 FR 67777) Federal Register Notice
provides the current protocol for allowing such drivers to operate CMVs
in interstate commerce.
These three applicants have had ITDM over a range of 5 to 9 years.
These applicants report no hypoglycemic reaction that resulted in loss
of consciousness or seizure, that required the assistance of another
person, or resulted in impaired cognitive function without warning
symptoms in the past 5 years (with one year of stability following any
such episode). In each case, an endocrinologist has verified that the
driver has demonstrated willingness to properly monitor and manage
their diabetes, received education related to diabetes management, and
is on a stable insulin regimen. These drivers report no other
disqualifying conditions, including diabetes-related complications.
Each meets the vision standard at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the October 19, 2005, Notice (70 FR
23904). Because there were no docket comments on the specific merits or
qualifications of any applicant, we have not repeated the individual
profiles here.
Basis for Exemption Determination
Under 49 U.S.C. 31315 and 31136(e), FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologist's medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that exempting two of these applicants
from the diabetes standard in 49 CFR 391.41(b)(3) is likely to achieve
a level of safety equal to that existing without the exemption. The
Agency is granting the exemptions for the 2-year period allowed by 49
U.S.C. 31315 and 31136(e) to Doyle F. Heiner and James R. Moretz. Once
the Agency has received the requested information from Mr. Witsch, it
will be reviewed, and a final determination will be published in a
separate Federal Register Notice.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document.
Discussion of Comments
FMCSA received three comments in this proceeding through the DMS.
The comments were considered and are discussed below.
Heather M. Murphy commented that she does not believe that it is
fair that an insulin dependent person is now able to receive an
exemption to drive in interstate commerce without three years of
driving experience while taking insulin, and individuals applying for a
Federal vision exemption must still meet this three years of experience
requirement. She believes that all exemptions should go by the same
standards and she requests that FMCSA reconsider the Federal vision
exemption requirements.
FMCSA recognizes the current differences between the Federal
Diabetes Exemption Program and the Federal Vision Exemption Program
related to driving experience criteria. FMCSA has used recent driving
experience in evaluating future safety, based on several research
studies designed to correlate past and future driving performance.
Results of these studies support the principle that the best predictor
of future performance by a driver is his/her past record of crashes and
traffic violations. Copies of these studies may be found at docket
number FMCSA-98-3637. The implementation of SAFETEA-LU mandated the
removal of the three year driving requirement from the Federal diabetes
exemption eligibility criteria.
The Agency has begun initiatives to evaluate if the driving
experience criteria should remain part of the Federal Vision Exemption
Program. FMCSA has begun a Federal Vision Exemption Program evaluation.
One portion of this evaluation will focus on determining if drivers
with certain
[[Page 17159]]
visual deficiencies are as safe or safer than drivers in the general
population. FMCSA also published a Federal Register Notice announcing
the establishment of a Medical Review Board (MRB) on October 3, 2005
(70 FR 57642). The MRB is scheduled to review the vision standard
during the third quarter of 2006. The driving experience criteria will
remain in effect for the Federal Vision Exemption Program until the
conclusion of these initiatives.
Two additional comments received were in favor of granting the
exemptions and supported the approach FMCSA takes in evaluating the
exemption candidates.
Conclusion
After considering the comments to the docket and based upon its
evaluation of the 3 exemption applications, FMCSA exempts Doyle F.
Heiner and James R. Moretz from the diabetes requirement in 49 CFR
391.41(b)(3), subject to the conditions listed under ``Conditions and
Requirements'' above.
In accordance with 49 U.S.C. 31315 and 31136(e), each exemption
will be valid for two years unless revoked earlier by FMCSA. The
exemption will be revoked if: (1) The person fails to comply with the
terms and conditions of the exemption; (2) the exemption has resulted
in a lower level of safety than was maintained before it was granted;
or (3) continuation of the exemption would not be consistent with the
goals and objectives of 49 U.S.C. 31315 and 31136. If the exemption is
still effective at the end of the 2-year period, the person may apply
to the FMCSA for a renewal under procedures in effect at that time.
Issued on: March 29, 2006.
Rose A. McMurray,
Associate Administrator, Policy and Program Development.
[FR Doc. E6-4898 Filed 4-4-06; 8:45 am]
BILLING CODE 4910-EX-P